Back to mobile site

UBS Cuts Outlook on Capital Product (CPLP); Market Softened, Challenges Continue

August 24, 2012 10:00 AM EDT Send to a Friend
UBS maintains a 'Buy' on Capital Product (NASDAQ: CPLP) price target of $8.40 (from $10.50).

Analyst, Ronald J. Barone ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login